Paroxysmal tachycardia-related age-adjusted mortality rates per 100,000, stratified by race in adults in the United States, 1999 to 2020. by Aman Goyal (19231397)

Subjects:

Overall and sex-stratified paroxysmal tachycardia-related age-adjusted mortality rates per 100,000 in adults in the United States, 1999 to 2020. by Aman Goyal (19231397)

Subjects:

Paroxysmal tachycardia-related age-adjusted mortality rates per 100,000, stratified by census regions in adults in the United States, 1999 to 2020. by Aman Goyal (19231397)

Subjects:

Paroxysmal tachycardia-related age-adjusted mortality rates per 100,000, stratified by age groups in adults in the United States, 1999 to 2020. by Aman Goyal (19231397)

Subjects:

Paroxysmal tachycardia-related deaths and age-adjusted mortality rates per 100,000, stratified by state in adults in the United States, 1999 to 2020. by Aman Goyal (19231397)

Subjects:

Paroxysmal tachycardia-related age-adjusted mortality rates per 100,000 in adults in the metropolitan and non-metropolitan areas in the United States, 1999 to 2020. by Aman Goyal (19231397)

Subjects:

Schematic diagram of monitoring points and units. by Jie Zhao (49409)

Model monitoring points and units coordinates. by Jie Zhao (49409)

Estimated distribution of colorectal cancer stage among patients assumed to have missed diagnosis in 2011 (unit: persons). by Hiroaki Saito (24514)

Subjects:

Loss of life expectancy that would result if colorectal cancer missed in 2011 had been diagnosed in 2011 (unit: years). by Hiroaki Saito (24514)

Subjects:

Patient demographic information at four time points. by Ruitian Song (11045127)

Subjects:

Innovation and night light in large and small cities. by Saul Estrin (8629173)

Centrifuged FMT products consistently exhibit the lowest median log₁₀ drop of CFU/g following freezing and lyophilization. In contrast, unprocessed feces exhibited the g... by Nina K. Randolph (21030732)

The importance of entry criteria from the point of view of the SD method ‐ combination A. by Roman Vavrek (13200141)

Subjects:

Primary and secondary efficacy end points (intention-to-treat population). by Benjamin R. Lewis (22279166)

Subjects:

The importance of entry criteria from the point of view of the SD method ‐ combinations D1 –D10. by Roman Vavrek (13200141)

Subjects:

The importance of entry criteria from the point of view of the SD method ‐ combinations B1 –B5. by Roman Vavrek (13200141)

Subjects:

The importance of entry criteria from the point of view of the SD method ‐ combinations C1 –C10. by Roman Vavrek (13200141)

Subjects:

Variables, the Time Points Collected, and the Number of Nurses Who Responded. by Rachel G. Baskin (22127334)

Subjects:

Join-point regression analysis of the statistically significant linear increase in use of antidepressants during the observed time period. by Jelena Filimonovic (22305307)